The neuropathological hallmark of MJD patients is the accumulation of ATXN3 protein-containing aggregates in brain tissue; the severity of the disease is directly correlated with the amount of such aggregates. The gene discussed is ATXN3; the disease is Spinocerebellar ataxia type 3.